Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis

被引:15
|
作者
Cancela Diez, Barbara [1 ]
Perez-Ramirez, Cristina [2 ]
del Mar Maldonado-Montoro, Maria [3 ]
Isabel Carrasco-Campos, Maria [1 ]
Sanchez Martin, Almudena [1 ]
Pineda Lancheros, Laura Elena [1 ]
Martinez-Martinez, Fernando [4 ]
Angel Calleja-Hernandez, Miguel [2 ]
Carmen Ramirez-Tortosa, Maria [5 ]
Jimenez-Morales, Alberto [1 ]
机构
[1] Univ Hosp Virgen de las Nieves, Pharm Serv Pharmacogenet Unit, UGC Prov Farm Granada, Avda Fuerzas Armadas, Granada, Spain
[2] Univ Hosp Virgen Macarena, Pharm Serv Pharmacogenet Unit, Seville, Spain
[3] Hosp Campus Salud, Clin Anal Serv, Av Invest S-N, Granada 18016, Spain
[4] Univ Granada, Dept Pharm & Pharmaceut Technol, Social & Legal Assistance Pharm Sect, Fac Pharm, Campus Univ Cartuja S-N, Granada 18071, Spain
[5] Univ Granada, Fac Pharm, Dept Biochem, Campus Univ Cartuja S-N, Granada 18071, Spain
来源
PHARMACOGENETICS AND GENOMICS | 2021年 / 31卷 / 02期
关键词
multiple sclerosis; polymorphisms; risk; VDR gene; CD4(+) T-CELLS; 25-HYDROXYVITAMIN D; GENE POLYMORPHISMS; D METABOLISM; RHEUMATOID-ARTHRITIS; LOW-PREVALENCE; RELAPSE RISK; DISABILITY; INTERLEUKIN-2; TRANSCRIPTION;
D O I
10.1097/FPC.0000000000000420
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Multiple sclerosis (MS) is a neurodegenerative chronic inflammatory. Mutations in the vitamin D receptor (VDR) gene can substantially affect serum vitamin D levels or alter its functionality, and can consequently increase susceptibility to developing MS. The objective of this study was to evaluate the association between polymorphisms in the VDR gene and risk of MS in a (Spanish) Caucasian population. Patients and methods We conducted a retrospective case-control study comprising 209 patients with relapsing-remitting multiple sclerosis (RRMS) and 836 controls of Caucasian origin from southern Spain. The ApaI (rs7975232), BsmI (rs1544410), Cdx2 (rs11568820), FokI (rs2228570), and TaqI (rs731236) gene polymorphisms were determined by allelic discrimination real-time PCR using TaqMan probes. Results The recessive logical regression model, adjusted for age and sex, revealed that the TT genotype for VDR FokI (rs2228570) polymorphism was associated with higher risk of MS (P = 0.0150; OR = 1.82; 95% CI = 1.12-2.94; TT vs. CT + CC). No association between the other polymorphisms and development of MS was found in any of the models analyzed. The haplotype analysis, adjusted for age, smoking, and sex, did not find any statistically significant association between the haplotypes analyzed and risk of MS. Conclusions The VDR FokI (rs2228570) polymorphism was significantly associated with developing MS. We found no influence of the ApaI (rs7975232), BsmI (rs1544410), Cdx2 (rs11568820), FokI (rs2228570), and TaqI (rs731236) gene polymorphisms on the risk of developing MS in our patients.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [31] Association between vitamin D receptor polymorphisms and osteoporosis in patients with COPD
    Kim, Sei Won
    Lee, Jong Min
    Ha, Jick Hwan
    Kang, Hyeon Hui
    Rhee, Chin Kook
    Kim, Jin Woo
    Moon, Hwa Sik
    Baek, Ki Hyun
    Lee, Sang Haak
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1809 - 1817
  • [32] Association between vitamin D receptor polymorphisms and haplotypes with pulmonary tuberculosis
    Salimi, Saeedeh
    Farajian-Mashhadi, Farzaneh
    Alavi-Naini, Roya
    Talebian, Golbarg
    Narooie-Nejad, Mehrnaz
    BIOMEDICAL REPORTS, 2015, 3 (02) : 189 - 194
  • [33] Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: A meta-analysis
    Zhang, Zi-Teng
    He, Yi-Chuan
    Ma, Xiu-Juan
    Li, Dian-You
    Lu, Guo-Cai
    NEUROSCIENCE LETTERS, 2014, 578 : 122 - 127
  • [34] Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis
    Gao, Jinzhao
    Teng, Jijun
    Liu, Zongchao
    Cai, Min
    Xie, Anmu
    NEUROSCIENCE LETTERS, 2020, 720
  • [35] Association between vitamin D receptor gene polymorphisms and susceptibility to tuberculosis: a systematic review and meta-analysis
    Tao, Rongshan
    Xiao, Shujuan
    Wang, Lianping
    Hu, Chunjie
    Suo, Huiqin
    Long, Ruiyu
    Liu, Hangyu
    Luo, Wei
    Hong, Feng
    Zhao, Jingming
    Li, Qingjie
    FRONTIERS IN GENETICS, 2024, 15
  • [36] Vitamin D deficiency and vitamin D receptor polymorphisms as the enviromental risk factors for paediatric multiple sclerosis in Poland
    Bilska, M.
    Kotulska, K.
    Jozwiak, S.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 659 - 659
  • [37] Association of Genetic Polymorphisms in Vitamin D Receptor Gene and Susceptibility to Sporadic Prostate Cancer
    Onen, Ilke Hacer
    Ekmekci, Abdullah
    Eroglu, Muzaffer
    Konac, Ece
    Yesil, Suleyman
    Biri, Hasan
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (12) : 1608 - 1614
  • [38] Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis
    de Abreu, D. A. Fernandes
    Babron, M. C., I
    Rebeix, C.
    Fontenille, J.
    Yaouanq, D.
    Brassat, B.
    Fontaine, F.
    Clerget-Darpoux, F.
    Jehan, F.
    Feron, F.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (10) : 1146 - 1152
  • [39] Association of vitamin D receptor gene polymorphism with reduced disability in multiple sclerosis
    Mamutse, G.
    Woolmore, J. A.
    Alldersea, J.
    Boggild, M.
    Young, C. A.
    Fryer, A. A.
    Strange, R. C.
    Hawkins, C. P.
    JOURNAL OF NEUROLOGY, 2006, 253 : 50 - 51
  • [40] Vitamin D and Multiple Sclerosis; Is There a Real Association?
    Al Brahim, Mustafa Mohammed
    Aldosari, Omar Muhammed
    Alyahya, Saeed Ali Saeed
    Alahmari, Faisal Saeed Mohammad
    Almalki, Laila Zawan Ali
    Alshammari, Abdulaziz Muqbil Faleh
    Albahrani, Ahmed Khalifah
    Albahrani, Tahani Abduljalil
    Aljabr, Saad Zaid
    Alrashdi, Faleh Mansour
    Alghamdi, Shahad Ghurmullah
    Alzahrani, Mohannad Abdulrahman D.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (02): : 129 - 133